why choose us

First received: August 26, 2024

Clinical Trial: Phase 1 Clinical Trial of CordSTEM-ST

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Premature Ovarian Insufficiency

Study Type: INTERVENTIONAL


Official Title: Single-dose, Phase 1 Clinical Trial to Evaluate the Safety, and Tolerability of Allogeneic Umbilical Cord-derived Mesenchymal Stem Cell Therapy in Patients With Premature Ovarian Insufficiency

Brief Summary: This clinical study will evaluate the safety and tolerability of CordSTEM-ST after administering a single dose in patients with premature ovarian insufficiency (POI), as well as identify the maximum tolerated dose (MTD) and evaluate the potential therapeutic effects.

Read more